Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin
- PMID: 19249912
- DOI: 10.33549/physiolres.931706
Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin
Abstract
Hepcidin is a key regulator of iron homeostasis, while hemojuvelin is an important component of the hepcidin regulation pathway. It has been recently proposed that soluble hemojuvelin, produced from hemojuvelin by the protease furin, decreases hepcidin expression. The aim of the presented study was to examine the downregulation of hepcidin by chronic bleeding in hemojuvelin-mutant mice. Male mice with targeted disruption of the hemojuvelin gene (Hjv-/- mice) and wild-type littermates were maintained on an iron-deficient diet and subjected to weekly phlebotomies for 7 weeks. Gene expression was examined by real-time PCR. In wild type mice, repeated bleeding decreased hepcidin mRNA by two orders of magnitude. In Hjv-/- mice, basal hepcidin expression was low; however, repeated bleeding also decreased hepcidin mRNA content by an order of magnitude. Phlebotomies reduced hepatic iron overload in Hjv-/- mice by 80 %. Liver and muscle furin mRNA content was not significantly changed. No effect on hepatic Tmprss6 mRNA content was observed. Results from the study indicate that soluble hemojuvelin is not the sole factor responsible for hepcidin downregulation. In addition, the presented data suggest that, under in vivo conditions, tissue hypoxia does not transcriptionally regulate the activity of furin or TMPRSS6 proteases.
Similar articles
-
Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis.Blood. 2008 Jan 15;111(2):924-31. doi: 10.1182/blood-2007-07-100677. Epub 2007 Oct 15. Blood. 2008. PMID: 17938254
-
Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in Mask Mice.Int J Mol Sci. 2021 Mar 6;22(5):2650. doi: 10.3390/ijms22052650. Int J Mol Sci. 2021. PMID: 33800732 Free PMC article.
-
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.Blood. 2013 Feb 14;121(7):1200-8. doi: 10.1182/blood-2012-09-453977. Epub 2012 Dec 6. Blood. 2013. PMID: 23223430 Free PMC article.
-
Hemojuvelin: the hepcidin story continues.Kidney Blood Press Res. 2009;32(2):71-6. doi: 10.1159/000208988. Epub 2009 Mar 14. Kidney Blood Press Res. 2009. PMID: 19287179 Review.
-
Regulation of hepcidin and iron-overload disease.Annu Rev Pathol. 2009;4:489-515. doi: 10.1146/annurev.pathol.4.110807.092205. Annu Rev Pathol. 2009. PMID: 19400694 Review.
Cited by
-
Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients?Int Urol Nephrol. 2012 Dec;44(6):1805-11. doi: 10.1007/s11255-011-0084-x. Epub 2011 Dec 1. Int Urol Nephrol. 2012. PMID: 22130959 Free PMC article.
-
Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis.Haematologica. 2012 Jun;97(6):827-34. doi: 10.3324/haematol.2011.056119. Epub 2011 Dec 29. Haematologica. 2012. PMID: 22207682 Free PMC article.
-
Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis.Adv Nutr. 2010 Nov;1(1):38-45. doi: 10.3945/an.110.1009. Epub 2010 Nov 16. Adv Nutr. 2010. PMID: 22043450 Free PMC article.
-
Novel tools for the evaluation of iron metabolism.Haematologica. 2010 Dec;95(12):1989-91. doi: 10.3324/haematol.2010.033993. Haematologica. 2010. PMID: 21123438 Free PMC article. No abstract available.
-
Liver and muscle hemojuvelin are differently glycosylated.BMC Biochem. 2011 Sep 21;12:52. doi: 10.1186/1471-2091-12-52. BMC Biochem. 2011. PMID: 21936923 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical